Benchling
R&D Cloud powering biotech research — experiments, samples, and lab data management.
Healthcare
📍 San Francisco, USA
Founded 2012
Current Valuation
$6.1B
as of 2021-Q4
UNICORN
Benchling builds the leading R&D Cloud for biotechnology, used by thousands of labs to manage experiments, sample inventory, lab workflows, and bioregistries. The company was last valued at $6.1B in its November 2021 Series F and is widely viewed as an IPO candidate as biotech software consolidates.
Company Profile
Est. Revenue
$185M (2023-Q4)
Last Round
Series F — $100M (Nov 2021) · Lead: Altimeter Capital
Founders & Key People
Sajith WickramasekaraAshu Singhal
Investors
Altimeter Capital · Franklin Templeton · Tiger Global · Lone Pine Capital · Sequoia Capital · Benchmark · Thrive Capital
Products
- Notebook
- Inventory
- Workflows
- Registry
- Insights analytics
- Bioregistry
Competitors
LabVantage · Dotmatics · STARLIMS · Scilligence · Sapio Sciences
healthtechbiotechsaasr-and-dlife-sciences
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q4. Refreshed quarterly.